In this review, we focused on the mutual or opposite roles of ATP and adenosine in retinal cells linked to the three types of blinding diseases (AMD, glaucoma, and DR), as well as emphasized the therapeutic potential of agonists and antagonists of ATP receptors and ARs for these diseases. The gene discussed is P2RY1; the disease is age-related macular degeneration.